High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes

References

• Ohgaki H, Kleihues P, Kleihues P, et al. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109(1):93–108. Acta Neuropathol (Berl).
   PubMed Web of Science ®Google Scholar
• Larjavaara S, Maentylae R, Salminen T, et al. Incidence of gliomas by anatomic location. Neuro Oncol. 2007;9(3):319.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Gittleman H, Stetson L, et al. Epidemiology of intracranial gliomas. Prog Neurol Surg. 2018;30:1–11.
   PubMedGoogle Scholar
• Liu Y, Hu H, Wang K, et al. Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas. Oncotarget. 2014;5(24):12593–12606.
   PubMedGoogle Scholar
• Hsu K, Whitham E, Kichenadasse G. Potential role of cannabidiol for seizure control in a patient with recurrent glioma. J Clin Neurosci. 2019;71:275–276.
   PubMed Web of Science ®Google Scholar
• Lemee JM, Clavreul A, Menei P. Intratumoral heterogeneity in glioblastoma: don’t forget the peritumoral brain zone. Neuro Oncol. 2015;17(10):1322–1332.
   PubMed Web of Science ®Google Scholar
• Xia P, Li Q, Wu G, et al. An immune-related lncRNA signature to predict survival in glioma patients. Cell Mol Neurobiol. 2021;41(2):365–375.
   PubMed Web of Science ®Google Scholar
• Akhir M, Choy CS, Abdullah MA, et al. The role of ISL1 and LHX5 LIM homeobox genes in bladder tumourigenesis. Malays J Med Sci. 2020;27(1):37–45.
   PubMed Web of Science ®Google Scholar
• Ota T, Klausen C, Salamanca MC, et al. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells. Differentiation. 2009;77(2):162–171.
   PubMed Web of Science ®Google Scholar
• Schiemann SM, Martin-Duran JM, Borve A, et al. Clustered brachiopod hox genes are not expressed collinearly and are associated with lophotrochozoan novelties. Proc Natl Acad Sci U S A. 2017;114(10):E1913–E22.
   PubMed Web of Science ®Google Scholar
• Rezsohazy R, Saurin AJ, Maurel-Zaffran C, et al. Cellular and molecular insights into hox protein action. Development. 2015;142(7):1212–1227.
   PubMed Web of Science ®Google Scholar
• Fan W, Zhang C, and Cai J, et al. Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma. Oncotarget. 2017;8(32):53110–53123.
   PubMedGoogle Scholar
• Lin S, Zhang R, An X, et al. LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells. Oncogenesis. 2019;8(2):8.
   PubMedGoogle Scholar
• Li J, Ye M, Zhou C. Expression profile and prognostic values of HOXA family members in laryngeal squamous cell cancer. Front Oncol. 2020;10:368.
   PubMed Web of Science ®Google Scholar
• Omatu T. Overexpression of human homeobox gene in lung cancer A549 cells results in enhanced motile and invasive properties. Hokkaido Igaku Zasshi. 1999;74(5):367–376.
   PubMedGoogle Scholar
• Kim HJ, Roh MS, Son CH, et al. Loss of Med1/TRAP220 promotes the invasion and metastasis of human non-small-cell lung cancer cells by modulating the expression of metastasis-related genes. Cancer Lett. 2012;321(2):195–202.
   PubMed Web of Science ®Google Scholar
• Cheng S, Qian F, Huang Q, et al. HOXA4, down-regulated in lung cancer, inhibits the growth, motility and invasion of lung cancer cells. Cell Death Dis. 2018;9(5):465.
   PubMedGoogle Scholar
• Wang J, Su Z, Lu S, et al. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta. 2018;485:229–233.
   PubMed Web of Science ®Google Scholar
• Strathdee G, Sim A, Parker A, et al. Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL. Leukemia. 2006;20(7):1326–1329.
   PubMed Web of Science ®Google Scholar
• Gray S, Pandha HS, Michael A, et al. HOX genes in pancreatic development and cancer. Jop. 2011;12(3):216–219.
   PubMedGoogle Scholar
• Tang X, Jiang J, Zhu J, et al. HOXA4-regulated miR-138 suppresses proliferation and gefitinib resistance in non-small cell lung cancer. Mol Genet Genomics. 2018;294(1):1–9.
   PubMed Web of Science ®Google Scholar
• B ZZA, Knza C, and D QWA, et al., Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients - sciencedirect. Genom Proteom Bioinf. 2021;19(1):1–12.
   PubMed Web of Science ®Google Scholar
• Tomczak K, Czerwinska P, and Wiznerowicz M. The cancer genome atlas (TCGA): an immeasurable source of knowledge. Wspolczesna Onkologia-Contemporary Oncology. 2015;19:A68–77.
   PubMedGoogle Scholar
• Meltzer DPS. GEOquery: a bridge between the gene expression omnibus (GEO) and bioconductor. Bioinformatics. 2007;23(14):1846–1847.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
   PubMed Web of Science ®Google Scholar
• Thul PJ, Lindskog C. The human protein atlas: a spatial map of the human proteome. Protein Sci A Publ Protein Soc. 2017;27(1):233–244
   PubMed Web of Science ®Google Scholar
• Thul PJ, Lindskog C. The human protein atlas: a spatial map of the human proteome. Protein Sci. 2018;27(1):233–244. 10.1002/pro.3307.
   PubMed Web of Science ®Google Scholar
• Wen PY, Reardon DA. Neuro-oncology in 2015: progress in glioma diagnosis, classification and treatment. Nat Rev Neurol. 2016;12(2):69–70.
   PubMed Web of Science ®Google Scholar
• Grimm SA, Chamberlain MC. Brainstem glioma: a review. Curr Neurol Neurosci Rep. 2013;13(5). 10.1007/s11910-013-0346-3
   PubMed Web of Science ®Google Scholar
• Cooney T, Lane A, Bartels U, et al. HG-109contemporary survival endpoints: an international diffuse intrinsic pontine glioma registry study. Neuro Oncol. 2016;18(suppl 3):iii73.4–iii74.
   Google Scholar
• Wang Z, Wang Z, Zhang C, et al. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma. Cancer Sci. 2018;109(9):2697–2705.
   PubMed Web of Science ®Google Scholar
• Huang R, Li G, and Zhao Z, et al., RGS16 promotes glioma progression and serves as a prognostic factor. CNS Neurosci Ther. 2020;26(8):791–803.
   PubMed Web of Science ®Google Scholar
• Miller KR, Patel JN, Zhang Q, et al. HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy. Gynecol Oncol. 2018;149(1):155–162.
   PubMed Web of Science ®Google Scholar
• Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010;10(5):361–371.
   PubMed Web of Science ®Google Scholar
• Di Vinci A, Casciano I, Marasco E, et al. Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome. J Cancer Res Clin Oncol. 2012;138(1):35–47.
   PubMed Web of Science ®Google Scholar
• Kuo TL, Cheng KH, and Chen LT, et al. Deciphering the potential role of hox genes in pancreatic cancer. Cancers (Basel). 2019;11(5):734.
   Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550.
   PubMed Web of Science ®Google Scholar
• Phan TG, Croucher PI. The dormant cancer cell life cycle. Nat Rev Cancer. 2020;20(7):398–411.
   PubMed Web of Science ®Google Scholar
• Yin X, Yang G, Ma D, et al. Inhibition of cancer cell growth in cisplatin-resistant human oral cancer cells by withaferin-A is mediated via both apoptosis and autophagic cell death, endogenous ROS production, G2/M phase cell cycle arrest and by targeting MAPK/RAS/RAF signalling pathway. J buon. 2020;25(1):332–337.
   PubMed Web of Science ®Google Scholar
• Ren C, Ren T, Yang K, et al. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing’s sarcoma through the PI3K/Akt pathway. J Exp Clin Cancer Res. 2016;35(1):44.
   PubMedGoogle Scholar
• Kobayashi H, Boelte KC, Lin PC. Endothelial cell adhesion molecules and cancer progression. Curr Med Chem. 2007;14(4):377–386.
   PubMed Web of Science ®Google Scholar
• Groner B, von Manstein V. Jak Stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition. Mol Cell Endocrinol. 2017;451:1–14.
   PubMed Web of Science ®Google Scholar
• Jonsson P, Lin AL, Young RJ, et al. Genomic correlates of disease progression and treatment response in prospectively characterized gliomas. Clin Cancer Res off J Am Assoc Cancer Res. 2019;25(18):5537–5547.
   PubMed Web of Science ®Google Scholar
• Peng C, Qi XM, Miao LL, et al. 1,2:5,6-dianhydrogalactitol inhibits human glioma cell growth in vivo and in vitro by arresting the cell cycle at G(2)/M phase. Acta Pharmacol Sin. 2017;38(4):561–570.
   PubMed Web of Science ®Google Scholar
• Cavallaro U, Christofori G. Multitasking in tumor progression: signaling functions of cell adhesion molecules. Ann N Y Acad Sci. 2004;1014(1):58–66.
   PubMedGoogle Scholar
• Pencik J, Pham HT, Schmoellerl J, et al. JAK-STAT signaling in cancer: from cytokines to non-coding genome. Cytokine. 2016;87:26–36.
   PubMed Web of Science ®Google Scholar
• Xu CH, Liu Y, Xiao LM, et al. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway. J Cell Physiol. 2019;234(12):22272–22284.
   PubMed Web of Science ®Google Scholar
• Ouyang Q, Xu L, Cui H, et al. MicroRNAs and cell cycle of malignant glioma. Int J Neurosci. 2016;126(1):1–9.
   PubMed Web of Science ®Google Scholar
• Li N, Shi H, Zhang L, et al. miR-188 inhibits glioma cell proliferation and cell cycle progression through targeting β-catenin. Oncol Res. 2018;26(5):785–794.
   PubMed Web of Science ®Google Scholar
• Huang W, Shi Y, Han B, et al. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p/TUSC2 axis. Hum Cell. 2020;33(2):416–426.
   PubMed Web of Science ®Google Scholar
• Se Y, Kim S, Kim J, et al. Underexpression of HOXA11 is associated with treatment resistance and poor prognosis in glioblastoma. Cancer Res Treat. 2017;49(2):387–398.
   PubMed Web of Science ®Google Scholar